Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1982 1
1984 1
1985 2
1986 1
1987 3
1988 1
1989 6
1990 4
1991 5
1992 6
1993 6
1994 4
1995 3
1996 3
1998 3
1999 7
2000 1
2001 4
2002 4
2003 3
2004 2
2005 5
2006 3
2007 6
2008 3
2009 3
2010 8
2011 5
2012 7
2013 2
2014 13
2015 12
2016 13
2017 7
2018 3
2019 5
2020 2
2021 5
2022 7
2023 5
2024 5
2025 3

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

183 results

Results by year

Filters applied: . Clear all
Page 1
Low-dose methylprednisolone treatment in critically ill patients with severe community-acquired pneumonia.
Meduri GU, Shih MC, Bridges L, Martin TJ, El-Solh A, Seam N, Davis-Karim A, Umberger R, Anzueto A, Sriram P, Lan C, Restrepo MI, Guardiola JJ, Buck T, Johnson DP, Suffredini A, Bell WA, Lin J, Zhao L, Uyeda L, Nielsen L, Huang GD; ESCAPe Study Group. Meduri GU, et al. Among authors: suffredini a. Intensive Care Med. 2022 Aug;48(8):1009-1023. doi: 10.1007/s00134-022-06684-3. Epub 2022 May 13. Intensive Care Med. 2022. PMID: 35723686 Free PMC article. Clinical Trial.
Adjunctive linezolid versus clindamycin for toxin inhibition in β-lactam-treated patients with invasive group A streptococcal infections in 195 US hospitals from 2016 to 2021: a retrospective cohort study with target trial emulation.
Babiker A, Warner S, Li X, Chishti EA, Saad E, Swihart BJ, Dekker JP, Walker M, Lawandi A, Kadri SS; NIH-Antimicrobial Resistance Outcomes Research Initiative. Babiker A, et al. Lancet Infect Dis. 2025 Mar;25(3):265-275. doi: 10.1016/S1473-3099(24)00507-3. Epub 2024 Oct 10. Lancet Infect Dis. 2025. PMID: 39396526
The Role of Interferon-γ in Autoimmune Polyendocrine Syndrome Type 1.
Oikonomou V, Smith G, Constantine GM, Schmitt MM, Ferré EMN, Alejo JC, Riley D, Kumar D, Dos Santos Dias L, Pechacek J, Hadjiyannis Y, Webb T, Seifert BA, Ghosh R, Walkiewicz M, Martin D, Besnard M, Snarr BD, Deljookorani S, Lee CR, DiMaggio T, Barber P, Rosen LB, Cheng A, Rastegar A, de Jesus AA, Stoddard J, Kuehn HS, Break TJ, Kong HH, Castelo-Soccio L, Colton B, Warner BM, Kleiner DE, Quezado MM, Davis JL, Fennelly KP, Olivier KN, Rosenzweig SD, Suffredini AF, Anderson MS, Swidergall M, Guillonneau C, Notarangelo LD, Goldbach-Mansky R, Neth O, Monserrat-Garcia MT, Valverde-Fernandez J, Lucena JM, Gomez-Gila AL, Garcia Rojas A, Seppänen MRJ, Lohi J, Hero M, Laakso S, Klemetti P, Lundberg V, Ekwall O, Olbrich P, Winer KK, Afzali B, Moutsopoulos NM, Holland SM, Heller T, Pittaluga S, Lionakis MS. Oikonomou V, et al. Among authors: suffredini af. N Engl J Med. 2024 May 30;390(20):1873-1884. doi: 10.1056/NEJMoa2312665. N Engl J Med. 2024. PMID: 38810185 Free PMC article.
R406 reduces lipopolysaccharide-induced neutrophil activation.
Warner S, Teague HL, Ramos-Benitez MJ, Panicker S, Allen K, Gairhe S, Moyer T, Parachalil Gopalan B, Douagi I, Shet A, Kanthi Y, Suffredini AF, Chertow DS, Strich JR. Warner S, et al. Among authors: suffredini af. Cell Immunol. 2024 Sep-Oct;403-404:104860. doi: 10.1016/j.cellimm.2024.104860. Epub 2024 Jul 26. Cell Immunol. 2024. PMID: 39084187 Free PMC article.
Response.
Torabi-Parizi P, Davey RT Jr, Suffredini AF, Chertow DS. Torabi-Parizi P, et al. Among authors: suffredini af. Chest. 2015 Aug;148(2):e65. doi: 10.1378/chest.15-0986. Chest. 2015. PMID: 26238847 Free PMC article. No abstract available.
SARS-CoV-2 Immune Complex-Mediated Neutrophil Activation.
Allen KC, Warner S, Teague HL, Ramos-Benitez MJ, Miao R, Tian X, Reger R, Burbelo PD, Pang CWJ, Kanthi Y, Cohen JI, Gopalan BP, Suffredini AF, King C, Nathan SD, Childs RW, Chertow DS, Strich JR. Allen KC, et al. Among authors: suffredini af. Open Forum Infect Dis. 2025 Apr 3;12(4):ofaf199. doi: 10.1093/ofid/ofaf199. eCollection 2025 Apr. Open Forum Infect Dis. 2025. PMID: 40256048 Free PMC article. Clinical Trial.
Difficult-to-Treat Resistance in Gram-negative Bacteremia at 173 US Hospitals: Retrospective Cohort Analysis of Prevalence, Predictors, and Outcome of Resistance to All First-line Agents.
Kadri SS, Adjemian J, Lai YL, Spaulding AB, Ricotta E, Prevots DR, Palmore TN, Rhee C, Klompas M, Dekker JP, Powers JH 3rd, Suffredini AF, Hooper DC, Fridkin S, Danner RL; National Institutes of Health Antimicrobial Resistance Outcomes Research Initiative (NIH–ARORI). Kadri SS, et al. Among authors: suffredini af. Clin Infect Dis. 2018 Nov 28;67(12):1803-1814. doi: 10.1093/cid/ciy378. Clin Infect Dis. 2018. PMID: 30052813 Free PMC article.
Reply.
Bornstein SR, Preas HL, Chrousos GP, Suffredini AF. Bornstein SR, et al. Among authors: suffredini af. J Infect Dis. 1999 Apr;179(4):1048. doi: 10.1086/314694. J Infect Dis. 1999. PMID: 10068610 No abstract available.
183 results